Patents Assigned to SPITFIRE PHARMA, INC.
  • Peptide pharmaceuticals for insulin resistance
    Patent number: 9856306
    Abstract: Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: January 2, 2018
    Assignee: SPITFIRE PHARMA, INC.
    Inventor: John J. Nestor